Placebo-controlled, double-blind study to assess efficacy and safety of oral vismodegib for the treatment of basal cell carcinoma preceding excision by Mohs micrographic surgery (MMS); version 3.0 dated February 22, 2012,
Role: Investigator,
Genentech, Inc.,
(07/2012 - 07/2013)
Status: Completed